First, the adenovirus comes in direct contact with the bladder cancer and, as a result, demonstrates potent anti-tumor activities (successful adenovirus-mediated wild-type p53 gene transfer) in patients with bladder cancer by intravesical vector instillation (Kuball et al., 2002; Benedict et al., 2004). The gene discussed is TP53; the disease is urinary bladder cancer.